The integration of these multiomics datasets through network-based approaches identified critical molecular hubs, including PIK3R1, IGF1, AKT1, IL6, JAK2, and STAT3, which represent promising therapeutic targets for addressing astrocyte dysfunction in fAD. Here, AKT1 is linked to familial Alzheimer disease.